Search

Displaying results 2821 - 2821 of 2821 in total
  1. Drug

    Resigratinib

    go.drugbank.com/drugs/DB21664
    Experimental

    Resigratinib is a small molecule drug. The usage of the INN stem '-gratinib' in the name indicates that Resigratinib is a fibroblast growth factor receptor (FGFR) inhibitor. Resigratinib has a monoisotopic molecular weight of 523.21 Da.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates